SLR Investment Corp

CONSOLIDATED SCHE DULE OF INVESTMENTS

(1)

Floating rate debt investments typically bear interest at a rate determined by reference to the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2023.

(2)

Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 in these controlled investments are as follows:

(1)

Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If the Company fails to invest a sufficient portion of its assets in qualifying assets, it could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2023, on a fair value basis, non-qualifying assets in the Company’s portfolio represented 26.6% of the total assets of the Company.

(2)

The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.

(3)

Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.

(4)

Aggregate net unrealized appreciation for U.S. federal income tax purposes is $2,567; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $97,678 and $95,111, respectively, based on a tax cost of $2,152,199. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the Credit Facility (as defined below) (see note 7 to the consolidated financial statements). The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

(5)

Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.

(6)

Denotes a Level 1 investment.

(7)

SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.

(8)

Indicates an investment that is wholly held by the Company through NEFPASS LLC.

(9)

Interest is paid in kind (“PIK”).

(10)

Denotes a subsidiary of SLR Equipment Finance.

(11)

OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.

(12)

Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.

(13)

Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.

(14)

Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC. Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(15)

See note 12 to the consolidated financial statements.

(16)

See note 13 to the consolidated financial statements.

(17)

See note 15 to the consolidated financial statements.

(18)

See note 11 to the consolidated financial statements.

(19)

See note 14 to the consolidated financial statements.

(20)

BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.

(21)

The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023.

(22)

Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.

(23)

See note 17 to the consolidated financial statements.

(24)

iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.

(25)

Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:

a Includes contribution of basis from Oldco AI, LLC to SLR-AMI Topco Blocker, LLC.

• Non-income producing security.

** Investment is on non-accrual status.